Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Elisaf

Showing results (141-150 of 248) with videos related to

Pageof 25
Sort By:
Cardiovascular Research|June 15, 2004
Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolaseLoukas D Tsironis, John V Mitsios, Haralampos J Milionis, et al.
Journal of Cardiology|March 27, 2019
Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesityFotios Barkas, Moses Elisaf, Evangelos Liberopoulos, et al.
European Journal of Internal Medicine|September 20, 2011
Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western GreeceMaria Diakou, George Miltiadous, Stavroulla L Xenophontos, et al.
Angiology|May 17, 2014
Lipid target achievement among patients with very high and high cardiovascular risk in a lipid clinicFotios Barkas, Evangelos N Liberopoulos, Michael S Kostapanos, et al.
Atherosclerosis|September 5, 2002
Effects of various fibrates on serum alkaline phosphatase activityEmanuel Ganotakis, Vasilios Tsimihodimos, Eleni Bairaktari, et al.
Metabolic Syndrome and Related Disorders|August 19, 2010
Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysisTheodoros Chimonas, Asterios Karagiannis, Vassilios G Athyros, et al.
Platelets|July 14, 2005
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromesJohn V Mitsios, Athanasios I Papathanasiou, Moses Elisaf, et al.
Journal of Gastroenterology and Hepatology|May 15, 2007
Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis CMichael Economou, Haralampos Milionis, Spyridon Filis, et al.
International Journal of Molecular Sciences|December 3, 2020
Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 DiabetesChristina E Kostara, Eleuterio Ferrannini, Eleni T Bairaktari, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 1, 2017
Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome ProjectHaralampos Milionis, George Ntaios, Vasileios Papavasileiou, et al.
Pageof 25

Showing results (141-150 of 248) with videos related to

Sort By:
Pageof 25
Cardiovascular Research|June 15, 2004
Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolaseLoukas D Tsironis, John V Mitsios, Haralampos J Milionis, et al.
Journal of Cardiology|March 27, 2019
Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesityFotios Barkas, Moses Elisaf, Evangelos Liberopoulos, et al.
European Journal of Internal Medicine|September 20, 2011
Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western GreeceMaria Diakou, George Miltiadous, Stavroulla L Xenophontos, et al.
Angiology|May 17, 2014
Lipid target achievement among patients with very high and high cardiovascular risk in a lipid clinicFotios Barkas, Evangelos N Liberopoulos, Michael S Kostapanos, et al.
Atherosclerosis|September 5, 2002
Effects of various fibrates on serum alkaline phosphatase activityEmanuel Ganotakis, Vasilios Tsimihodimos, Eleni Bairaktari, et al.
Metabolic Syndrome and Related Disorders|August 19, 2010
Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysisTheodoros Chimonas, Asterios Karagiannis, Vassilios G Athyros, et al.
Platelets|July 14, 2005
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromesJohn V Mitsios, Athanasios I Papathanasiou, Moses Elisaf, et al.
Journal of Gastroenterology and Hepatology|May 15, 2007
Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis CMichael Economou, Haralampos Milionis, Spyridon Filis, et al.
International Journal of Molecular Sciences|December 3, 2020
Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 DiabetesChristina E Kostara, Eleuterio Ferrannini, Eleni T Bairaktari, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 1, 2017
Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome ProjectHaralampos Milionis, George Ntaios, Vasileios Papavasileiou, et al.
Pageof 25